Certis Oncology, an AI-enabled translational science company, today announced the launch of Certis Oncology Intelligence ®, an integrated platform designed to generate data-driven insights into ...
This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical ...
PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data ...
Stanford Medicine has developed a vision-language artificial intelligence (AI) model that can predict cancer outcomes, such as forecasting melanoma relapses and patient responses to immunotherapy.
Key market opportunities include the rising demand for AI-enhanced trial design, boosted by increasing complexity in clinical ...
We recently published a list of Top 10 Trending AI News On Wall Street’s Radar. In this article, we are going to take a look at where Predictive Oncology Inc. (NASDAQ:POAI) stands against other top ...
Zohar Bronfman is the cofounder and CEO of Pecan AI, a predictive analytics platform making advanced AI accessible to business teams. For decades, predictive analytics was a capability largely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results